We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+12.82%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$161M
AUM Growth
–
Cap. Flow
+$155M
Cap. Flow %
96.34%
Top 10 Hldgs %
42.42%
Holding
67
New
67
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$9.98M
2
WSTC
West Corporation
WSTC
+$9.96M
3
ARMK icon
Aramark
ARMK
+$9.51M
4
ZEN
ZENDESK INC
ZEN
+$8.38M
5
EVHC
Envision Healthcare Holdings Inc
EVHC
+$7.27M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 32.26%
2 Technology 13.57%
3 Industrials 13.18%
4 Financials 8.4%
5 Consumer Discretionary 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBLY
51
DELISTED
Mobileye N.V.
MBLY
$841K 0.52%
+20,000
New +$779K
CONE
52
DELISTED
CyrusOne Inc Common Stock
CONE
$778K 0.48%
+25,000
New +$738K
TTPH
53
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$733K 0.46%
+1,000
New +$751K
ASMB icon
54
Assembly Biosciences
ASMB
$529M
$636K 0.4%
+4,000
New +$541K
INOV
55
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$579K 0.36%
+19,150
New +$574K
CLDX icon
56
Celldex Therapeutics
CLDX
$3.28B
$557K 0.35%
+1,333
New +$477K
NVTA
57
DELISTED
Invitae Corporation
NVTA
$540K 0.34%
+32,232
New +$597K
REXR icon
58
Rexford Industrial Realty
REXR
$8.19B
$517K 0.32%
+32,691
New +$523K
TRIL
59
DELISTED
Trillium Therapeutics Inc.
TRIL
$506K 0.32%
+25,000
New +$369K
STDY
60
DELISTED
SteadyMed Ltd
STDY
$468K 0.29%
+55,000
New +$471K
DERM
61
DELISTED
Dermira, Inc.
DERM
$399K 0.25%
+25,965
New +$436K
IOVA icon
62
Iovance Biotherapeutics
IOVA
$2.87B
$378K 0.24%
+31,200
New +$351K
XNCR icon
63
Xencor
XNCR
$1.55B
$339K 0.21%
+22,140
New +$349K
CASC
64
DELISTED
Cascadian Therapeutics, Inc.
CASC
$326K 0.2%
+33,333
New +$327K
BOOT icon
65
Boot Barn
BOOT
$4.95B
$239K 0.15%
+10,000
New +$223K
BIOA.WS
66
DELISTED
BioAmber Inc.
BIOA.WS
$239K 0.15%
+150,000
New +$248K
SEDG icon
67
SolarEdge
SEDG
$1.95B
$219K 0.14%
+10,000
New +$214K
1 2
3

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q1 2015 Portfolio in Review

Q1 2015 is the first quarter with a 13F filing on record for Monashee Investment Management, which disclosed 67 positions worth $161M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Viatris: 175,000 shares worth $10.4M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, followed by Technology and Industrials.

  • Monashee Investment Management's largest Q1 2015 buy was Viatris: 175,000 shares worth $10.4M.
  • Monashee Investment Management's ten largest holdings make up 42% of its $161M portfolio in Q1 2015.
  • Monashee Investment Management disclosed 67 positions in Q1 2015, its first 13F filing on record.

Based on Monashee Investment Management's 13F filing for Q1 2015, filed 20 Apr 2015.